Leptomeningeal disease from melanoma—Poor prognosis despite new therapeutic modalities

Autor: Chorti, Eleftheria, Kebir, Sied, Ahmed, Misbah S., Keyvani, Kathy, Umutlu, Lale, Kanaki, Theodora, Zaremba, Anne, Reinboldt-Jockenhoefer, Finja, Knispel, Sarah, Gratsias, Emmanouil, Roesch, Alexander, Ugurel, Selma, Scheffler, Björn, Schadendorf, Dirk, Livingstone, Elisabeth, Meier, Friedegund, Glas, Martin, Zimmer, Lisa

Publikováno v: In European Journal of Cancer May 2021 148:395-404

Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival.

Autor: Vallée TC; Pediatric Hematology/Oncology, Dr von Hauner University Children's Hospital, Munich, Germany., Glasmacher JS; Pediatric Hematology/Oncology, Dr von Hauner University Children's Hospital, Munich, Germany., Buchner H; Staburo GmbH, Munich, Germany., Arkwright PD; Lydia Becker Institute of Immunology and Inflammation, The University of Manchester & Royal Manchester Children's Hospital, Manchester, United Kingdom., Behrends U; Children's Hospital, School of Medicine, Technical University Munich, Munich, Germany., Bondarenko A; Department of Pediatrics, Immunology, Infectious and Rare Diseases and Allergology, European Medical School, International European University, Kyiv, Ukraine., Browning MJ; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, United Kingdom., Buchbinder D; Department of Hematology, Children's Hospital of Orange County, Orange, CA., Cattoni A; Department of Pediatrics, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.; School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy., Chernyshova L; Department of Pediatrics, Pediatric Infectious Diseases, Immunology and Allergology, Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine., Ciznar P; Department of Pediatrics, Faculty of Medicine, Comenius University, Bratislava, Slovakia., Cole T; Department of Allergy and Immunology, The Royal Children's Hospital, Melbourne, Australia., Czogała W; Department of Pediatric Oncology and Hematology, Institute of Pediatrics, Jagiellonian University Medical College, Krakow, Poland., Dueckers G; Helios Kliniken Krefeld, Children's Hospital, Krefeld, Germany., Edgar JDM; St James's Hospital & School of Medicine, Trinity College, Dublin, Ireland., Erbey F; Department of Pediatric Hematology/Oncology, Koç University School of Medicine, İstanbul, Turkey., Fasth A; Department of Pediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Ferrua F; Pediatric Immunohematology and Stem Cell Program, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy., Formankova R; Department of Pediatric Hematology and Oncology, Charles University and University Hospital Motol, Prague, Czech Republic., Gambineri E; Department of NEUROFARBA, Section of Child's Health, University of Florence, Florence, Italy.; Department of Haematology-Oncology, Anna Meyer University Children's Hospital (AOU Meyer IRCCS), Florence, Italy., Gennery AR; Translational and Clinical Research Institute, Newcastle University, and Paediatric Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom., Goldman FD; Department of Pediatrics, The University of Alabama at Birmingham, Birmingham, AL., Gonzalez-Granado LI; Department of Pediatrics, Primary Immunodeficiencies Unit, Research Institute, Hospital 12 Octubre, School of Medicine, Complutense University of Madrid, Madrid, Spain., Heilmann C; Department for Children and Adolescents, Pediatric Hematopoietic Stem Cell Transplantation and Immunodeficiency, Copenhagen University Hospital Rigshospitalet, København, Denmark., Heiskanen-Kosma T; Department of Pediatrics, Kuopio University Hospital, Kuopio, Finland., Juntti H; Department of Pediatrics and Adolescent Medicine, Oulu University Hospital and Research Unit of Clinical Medicine, University of Oulu, Oulu, Finland., Kainulainen L; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Turku University Hospital, Turku, Finland., Kanegane H; Department of Child Health and Development, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan., Karaca NE; Division of Pediatric Immunology, Department of Pediatrics, Ege University, The Medical School, Izmir, Turkey., Kilic SS; Pediatric Immunology and Rheumatology, Bursa Uludag University School of Medicine, Bursa, Turkey., Klein C; Pediatric Hematology/Oncology, Dr von Hauner University Children's Hospital, Munich, Germany., Kołtan S; Department of Paediatrics, Haematology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Toruń, Poland., Kondratenko I; Russian Children's Clinical Hospital, Pirogov National Research Medical University, Moscow, Russia., Meyts I; Department of Pediatrics, University Hospitals Leuven, Leuven, Belgium., Nasrullayeva GM; Azerbaijan Medical University, Baku, Azerbaijan., Notarangelo LD; Medical Direction, Children's Hospital, ASST Spedali Civili, Brescia, Italy., Pasic S; Department of Immunology, Mother and Child Health Care Institute of Serbia, Belgrade, Serbia., Pellier I; Centre de référence des déficits immunitaires primitifs CEREDIH, CHU d'Angers, Angers, France., Pignata C; Department of Translational Medical Science, Section of Pediatrics, Federico II University, Napoli, Italy., Misbah S; Clinical Immunology, John Radcliffe Hospital, Oxford, United Kingdom., Schulz A; Department of Pediatrics, University Medical Center Ulm, Ulm, Germany., Segundo GR; Allergy and Immunology Division, Pediatrics Department, Universidade Federal de Uberlândia, Uberlândia, Brazil., Shcherbina A; Dmitry Rogachev National Research and Clinical Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia., Slatter M; Translational and Clinical Research Institute, Newcastle University, and Paediatric Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom., Sokolic R; Hematologic Malignancies Branch, Office of Therapeutic Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD., Soler-Palacin P; Pediatric Infectious Diseases and Immunodeficiencies Unit, Children's Hospital, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Stepensky P; Bone Marrow Transplantation Department, Hadassah-Hebrew, University Medical Center, Jerusalem, Israel., van Montfrans JM; Department of Pediatric Immunology and Infectious Diseases, University Medical Centre Utrecht, Utrecht, The Netherlands., Ryhänen S; Children's Hospital, University of Helsinki and Helsinki University Hospital, Pediatric Research Center, Helsinki, Finland., Wolska-Kuśnierz B; Department of Immunology, Children's Memorial Health Institute, Warsaw, Poland., Ziegler JB; School of Women's & Children's Health, University of New South Wales, Sydney, Australia., Zhao X; Department of Rheumatism and Immunology, Children's Hospital of Chongqing Medical University, Chongqing, China.; Vita-Salute San Raffaele University, Milan, Italy., Aiuti A; Pediatric Immunohematology and Stem Cell Program, San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy., Ochs HD; University of Washington School of Medicine, Seattle, WA., Albert MH; Pediatric Hematology/Oncology, Dr von Hauner University Children's Hospital, Munich, Germany.

Publikováno v: Blood [Blood] 2024 Jun 13; Vol. 143 (24), pp. 2504-2516.

Discovery of novel inhibitors of histone deacetylase 6: Structure-based virtual screening, molecular dynamics simulation, enzyme inhibition and cell viability assays.

Autor: Uba AI; Complex Systems Division, Beijing Computational Science Research Center, Beijing 100193, China., Hryb M; College of Science and Mathematics, Rowan University, Glassboro, NJ 08028, USA., Singh M; College of Science and Mathematics, Rowan University, Glassboro, NJ 08028, USA., Bui-Linh C; College of Science and Mathematics, Rowan University, Glassboro, NJ 08028, USA., Tran A; College of Science and Mathematics, Rowan University, Glassboro, NJ 08028, USA., Atienza J; College of Science and Mathematics, Rowan University, Glassboro, NJ 08028, USA., Misbah S; College of Science and Mathematics, Rowan University, Glassboro, NJ 08028, USA., Mou X; College of Science and Mathematics, Rowan University, Glassboro, NJ 08028, USA. Electronic address: moux@rowan.edu., Wu C; College of Science and Mathematics, Rowan University, Glassboro, NJ 08028, USA. Electronic address: wuc@rowan.edu.

Publikováno v: Life sciences [Life Sci] 2024 Feb 01; Vol. 338, pp. 122395. Date of Electronic Publication: 2024 Jan 03.

SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry

Autor: Moritz, Rose K.C., Gutzmer, Ralf, Zimmer, Lisa, Meier, Friedegund, Ahmed, Misbah S., Sell, Sabine, Schlaak, Max, Kapp, Florian, Sachse, Michael M., Haferkamp, Sebastian, Welzel, Julia, Kähler, Katharina C., Weichenthal, Michael

Publikováno v: In European Journal of Cancer February 2021 144:382-385

SARS-CoV-2 infections in melanoma patients treated with PD-1 inhibitors: A survey of the German ADOREG melanoma registry

Autor: Michael Max Sachse, Florian Kapp, Friedegund Meier, Rose K. C. Moritz, Lisa Zimmer, Katharina C. Kähler, Sebastian Haferkamp, Michael Weichenthal, Sabine Sell, Misbah S. Ahmed, Ralf Gutzmer, Max Schlaak, Julia Welzel

Publikováno v: European Journal of Cancer

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7523296efab65101793a258568235614